A BUNGED up nose is one of the many joys cold and flu season brings each year. Though having to dab at your streaming schnoz with tissues can be a real headache, most of us tend to assume that ...
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...